Cholesterol, LDL [bacs, strd]
standards [inpr]
treatment [ftcn]
German [popg]
Decreasing [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Few [qnco]
Established [qlco]
Proven [qlco]
Prevention [topp]
treatment [ftcn]
Atherosclerosis [dsyn]
CARDIOVASCULAR [bdsy]
Benefit [qnco]
Lipid [lipd]
lowering [spco]
Pharmacotherapy [topp]
treatment options [topp]
Chosen [acty]
Based [ftcn]
CARDIOVASCULAR [bdsy]
depend [medd]
Levels [qlco]
Cardiovascular disease [dsyn]
Severity [qlco]
risk factors [qnco]
Current [tmco]
Guidelines [inpr]
recommend [idcn]
lowering [spco]
mg dl [qnco]
mmol/L [qnco]
Patients [podg]
Moderate [qlco]
treatment [ftcn]
Target [ftcn]
mg dl [qnco]
mmol/L [qnco]
Patients [podg]
High Risk [qlco]
mg dl [qnco]
mmol/L [qnco]
Patients [podg]
Very high [fndg]
Life Style [socb]
Measures [qnco]
Part [spco]
treatment [ftcn]
Patients [podg]
Drug Therapy [topp]
Target [ftcn]
Statins [orch, phsu]
Drugs [phsu]
choice [inbe]
Options [ftcn]
Including [ftcn]
ezetimibe [orch, phsu]
newly [idcn]
Available [ftcn]
Monoclonal Antibodies [aapp, imft]
PCSK9 [gngm]
proprotein convertase subtilisin/kexin type 9 [gngm]
Cases [ftcn]
Bile Acid Sequestrants [phsu]
binding [ftcn]
Fibrates [orch, phsu]
considered [idcn]
Nicotinic Acid [orch, phsu, vita]
Long [qlco]
Available [ftcn]
Germany [geoa]
PCSK9 [gngm]
Antibodies [aapp, celc, imft]
Decrease [qlco]
Well [qlco]
effects [qlco]
Clinical Endpoint [clna]
investigated [ftcn]
Large [qnco]
randomized [resa]
Trial [resa]
Present [qnco]
Current [tmco]
Guidelines [inpr]
treatment options [topp]
Hypercholesterolaemia [dsyn]
PCSK9 [gngm]
Antibodies [aapp, celc, imft]
Select [acty]
At risk [qlco]
Very high [fndg]
CARDIOVASCULAR [bdsy]
Lipid-lowering therapy [topp]
treatment [ftcn]
Target [ftcn]
